Polymeric Nano/Microparticles for Oral Delivery of Proteins and Peptides - Biomaterials Fabrication and Processing - page 188

12. Zhou, X.H. Overcoming enzymatic and absorption barriers to non-parentally administrated protein and
peptide drugs. J. Con. Rel ., 29, 239, 1994.
13. Tandon V.R. P-glycoprotein: pharmacological relevance. Ind. J. Pharmacol ., 38, 13, 2006.
14. Fanaso, A. Novel approaches for oral delivery of macromolecules. J. Pharm. Sci ., 87, 1351, 1998.
15. Saffran, M. et al. A new approach to the oral administration of insulin and other peptide drugs. Science ,
233, 1081, 1986.
16. Gomez-Orellana, I. Strategies to improve oral drug bioavailability. Expert Opin. , 2, 119, 2005.
17. Bernkop-Schnurch, A. The use of inhibitory agents to overcome the enzymatic barrier to perorally
administrated therapeutic peptides and proteins. J. Con. Rel ., 52, 1, 1998.
18. Ward, P.D., Tippin, T.K., Thakker, D.R. Enhancing paracellular permeability by modulating epithelial
tight junctions. Pharm. Sci. Tech. Tod ., 3, 346, 2000.
19. Daugherty, A.L., Mrsny, R.J. Regulation of the intestinal epithelial paracellular barrier. Pharm. Sci.
Tech. Today , 2, 281, 1999.
20. Aungst, B.J. Intestinal permeation enhancers. J. Pharm. Sci ., 89, 429, 2000.
21. Mesiha, M.S., Ponnapula, S., Plakogiannis, F. Oral absorption of insulin encapsulated in artifi cial chyles
of bile salts, palmitic acid and α-tocopherol dispersions. Int. J. Pharm ., 249, 1, 2002.
22. Aungst, B.J. et al. Enhancement of the intestinal absorption of peptides and non-peptides. J. Con. Rel .,
41, 19, 1996.
23. Anderberg, E.K., Nystrom, C., Artusson, P. Epithelial transport of drugs in cell culture VII: effects of
pharmaceutical surfactants excipients and bile acids on transepithelial permeability in monolayers of
human intestinal epithelial (caco-2) cells. J. Pharm. Sci ., 81, 879, 1992.
24. Katre, N.V. The conjugation of proteins with poly(ethylene glycol) and other polymers altering proper-
ties of proteins to enhance their therapeutic potential. Adv. Drug Del. Rev ., 10, 91, 1993.
25. Allémann, E., Leroux, J.C., Gurny, R. Polymeric nano- and microparticles for the oral delivery of pep-
tides and peptidomimetics. Adv. Drug Del. Rev ., 34, 171, 1998.
26. Couvreur, P., Dubernet, C., Puisieux, F. Controlled drug delivery with nanoparticles: current possibili-
ties and future trends. Eur. J. Pharm. Biopharm ., 41, 2, 1995.
27. Soppimath, K.S., Aminabhavi, T.M., Kulkarni, A.R., Rudzinski, W.E. Biodegradable polymeric
nanoparticles as drug delivery devices. J. Con. Rel ., 70, 1, 2001.
28. Junga, T. et al. Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to
affect mucosal uptake? Eur. J. Pharm. Biopharm ., 50, 147, 2000.
29. Florence, A.T. The oral absorption of micro- and nanoparticulates: neither exceptional nor unusual.
Pharm. Res ., 14, 259, 1997.
30. Junginger, H.E., Verhoef, J.C. Macromolecules as safe penetration enhancers for hydrophilic drugs—a
fi ction? Pharm. Sci. Tech. Tod ., 1, 370, 1998.
31. Florence, A.T. Nanoparticle uptake by the oral route: fulfi lling its potential? Drug Dis. Tod. Tech ., 2, 75,
2005.
32. Delie, F., Blanco-Príeto, M.J. Polymeric particulates to improve oral bioavailability of peptide drugs.
Molecules , 10, 65, 2005.
33. Florence, A.T. Issues in oral nanoparticle drug carrier uptake and targeting. J. Drug Target , 12, 65,
2004.
34. Rubas, W., Grass, G.M. Gastrointestinal lymphatic absorption of peptides and proteins. Adv. Drug Del.
Rev ., 7, 15, 1991.
35. Volkheimer, G., Persorption von mikropartikeln, Pathologe , 14, 247, 1993.
36. Shakweh, M. et al. Particle uptake by Peyer's patches; a pathway for drug and vaccine delivery. Expert
Opin. Drug Deliv ., 1, 141, 2004.
37. Hussain, N. et al. Recent advances in the understanding of uptake of micro particulates across the gas-
trointestinal lymphatics. Adv. Drug Deliv. Rev ., 50, 107, 2001.
38. Clark, M.A., Jepson, M.A., Hirst, B.H. Exploiting M cells for drug and vaccine delivery. Adv. Drug Del.
Rev ., 50, 81, 2001.
39. Ermak, T.H., Giannasca, P.J. Microparticle targeting to M cells. Adv. Drug Deliv. Rev ., 34, 261, 1998.
40. Florence, A.T., Hussain, N. Transcytosis of nanoparticle and dendrimer delivery systems: evolving vis-
tas. Adv. Drug Deliv. Rev ., 50, S69, 2001.
41. Brayden, D. Oral vaccination in man using antigens in particles: current status. Eur. J. Pharm. Sci ., 14,
183, 2001.
42. Wasan, K.M. The role of lymphatic transport in enhancing oral protein and peptide. Drug Del. Ind.
Pharm ., 28, 1047, 2002.